EGFR-expression was associated with negative prognostic factors including ERα/PR-negativity, HER2-overexpression, high tumor stage, high Ki67, low age at diagnosis, lymph node metastasis, and larger tumor size at diagnosis. This evidence concerns the gene PGR and metastatic malignant neoplasm in the lymph nodes.